Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance
Naltrexone + Bupropion is a non-stimulant combination that can help support your weight management journey by working on brain pathways related to cravings, reward, and appetite regulation. This combination is non-habit-forming and may promote more mindful eating habits, especially if emotional or reward-driven eating has been a challenge. When used alongside healthy lifestyle changes, including diet and physical activity, it may contribute to sustainable weight loss over time.






Wegovy® is now available as a once-daily pill, offering a needle-free option for people who prefer oral medication. Like the Wegovy® pen, the pill contains semaglutide and is FDA-approved for chronic weight management.
This new delivery method gives patients more flexibility in how they take Wegovy®, while still receiving provider-guided care through Shed.

*In clinical trials of Wegovy® (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise. This compares to approximately 2–3% weight loss with diet and exercise alone.















Compounded medications are not reviewed or approved by the FDA. Prescription is only available after consultation with a licensed provider to determine if treatment is appropriate.




Naltrexone + Bupropion is a non-stimulant combination that can help support your weight management journey by working on brain pathways related to cravings, reward, and appetite regulation. This combination is non-habit-forming and may promote more mindful eating habits, especially if emotional or reward-driven eating has been a challenge. When used alongside healthy lifestyle changes, including diet and physical activity, it may contribute to sustainable weight loss over time.




Naltrexone + Bupropion is a non-stimulant combination that can help support your weight management journey by working on brain pathways related to cravings, reward, and appetite regulation. This combination is non-habit-forming and may promote more mindful eating habits, especially if emotional or reward-driven eating has been a challenge. When used alongside healthy lifestyle changes, including diet and physical activity, it may contribute to sustainable weight loss over time.







Doctor of Medicine (MD),
Internal Medicine Physician
While GLP-1 microdosing is ideal for maintenance, longevity, and overall wellness support, those with a significant weight-loss goal may be better suited for a standard GLP-1 dose.

Compounded medications are not reviewed or approved by the FDA. Prescription is only available after consultation with a licensed provider to determine if treatment is appropriate.
Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance